Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Diagnostic imaging in stage IV cancer on the rise

Diagnostic imaging in elderly patients with stage IV cancer has increased significantly in recent years, while its use among those with early-stage disease has decreased, suggest study findings.

6 Aug 2012

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $48.2 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer researchers.

6 Aug 2012

Potential drug targets and prognostic markers for prostate cancer

Two proteins that act in opposing directions - one that promotes cancer and one that suppresses cancer - regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

6 Aug 2012

Scientists identify key factor that drives resistance to cancer drug

Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors - such as those of the breast, prostate, lung and colon - that have metastasized, or spread, throughout the body. A team of scientists led by Fred Hutchinson Cancer Research Center has discovered a key factor that drives this drug resistance - information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer.

6 Aug 2012

Simpler and more accurate way to test for prostate cancer

An undergraduate student's technique for detecting certain metabolites in urine samples could lead to a simpler and more accurate way to test for prostate cancer.

3 Aug 2012

Advanced cancer patients able to state their own pain goals

Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.

2 Aug 2012

Surgery avoidable for some with persistent incontinence after prostatectomy

Researchers have identified factors that could help determine whether patients who have not recovered urinary continence more than 1 year after undergoing radical prostatectomy should undergo further surgery.

1 Aug 2012

Opinion of artificial hydration varies by ethnicity

Ethnicity influences whether patients at the end of life and their carers view artificial hydration as food or medicine, with more individuals from ethnic minorities viewing it as food than non-Hispanic European Americans, show US study results.

1 Aug 2012

MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.

1 Aug 2012

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

31 Jul 2012

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

A new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that PSA testing and early detection may prevent approximately 17,000 men each year from having such advanced prostate cancer at diagnosis.

30 Jul 2012

Research roundup: Slowdown in medical imaging; Hospitals' efforts mixed on reducing readmissions

Recent research showed a slowdown in the use of medical imaging for people enrolled in Medicare. This article follows up and finds that annual imaging growth slowed down from an average of 14 percent between 2000 and 2005 to 2.6 percent between 2006 and 2009. An analysis of commercial insurance claims shows a similar trend outside of Medicare. Based on

28 Jul 2012

PedBrain Tumor network publishes evaluation of first 125 genome analyses of medulloblastomas

Brain tumors are the primary cause of cancer mortality in children. Even if a cure is possible, young patients often suffer from the stressful treatment which can be harmful to the developing brain. The most common childhood brain tumors are medulloblastoma and pylocytic astrocytoma.

27 Jul 2012

Short-course palliative RT shows promise

A 2-day course of three-dimensional radiotherapy delivered in twice-daily fractions up to 18 Gy resulted in no dose-limiting toxicities, and high rates of symptom relief in patient with pelvic cancer, especially those with bleeding, report researchers.

26 Jul 2012

Virginia Hospital Center offers new Calypso System for patients with prostate cancer

Virginia Hospital Center is among the few hospitals along the east coast to offer the new Calypso® System featuring GPS for the Body technology and Beacon electromagnetic transponders for patients with certain types of cancer.

26 Jul 2012

Malaria commonly misdiagnosed and mistreated in Afghanistan

Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.

25 Jul 2012

Healthcare system perceptions predict PSA screening uptake

Study findings suggest that African–American and Afro–Caribbean men who have poor perceptions or experiences of their healthcare system are less likely to have prostate-specific antigen screening than those with positive healthcare experiences.

25 Jul 2012

Self-neglect predicts hospice use among elderly

Both the presence and severity of self-neglect in the elderly independently predict hospice use, and are not mediated by the presence of health-related factors, show results published in the Archives of Gerontology and Geriatrics.

25 Jul 2012

Central mechanism would remove physician from assisted-dying process

The development of a central state or federal mechanism in the USA that would confirm the authenticity and eligibility of terminally ill patients’ requests for death, dispense medication, and monitor demand and use, could remove physicians from the assisted dying process, say researchers.

24 Jul 2012

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.

24 Jul 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Diagnostic imaging in stage IV cancer on the rise

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

Potential drug targets and prognostic markers for prostate cancer

Scientists identify key factor that drives resistance to cancer drug

Simpler and more accurate way to test for prostate cancer

Advanced cancer patients able to state their own pain goals

Surgery avoidable for some with persistent incontinence after prostatectomy

Opinion of artificial hydration varies by ethnicity

MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

PSA testing and early detection may prevent 17,000 men each year from prostate cancer

Research roundup: Slowdown in medical imaging; Hospitals' efforts mixed on reducing readmissions

PedBrain Tumor network publishes evaluation of first 125 genome analyses of medulloblastomas

Short-course palliative RT shows promise

Virginia Hospital Center offers new Calypso System for patients with prostate cancer

Malaria commonly misdiagnosed and mistreated in Afghanistan

Healthcare system perceptions predict PSA screening uptake

Self-neglect predicts hospice use among elderly

Central mechanism would remove physician from assisted-dying process

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in